QIAGEN launches QCI Secondary Analysis, a new cloud-based secondary analysis solution for oncology and inherited disease applications that enables high-throughput...
The QCI Interpret Winter 2023 Release brings new variant assessment tools, functionality improvements, and expanded bibliographic coverage for carrier screening...
QIAGEN Digital Insights Thursday, October 27, 2022
Peer-reviewed study compares accuracy and consistency of variant assessments from commercial CDS software to the variant interpretation of 8 laboratories...
The industry-leading NGS variant interpretation and reporting software now includes a new Clinical Validity feature, Dynamic Candidate Disease Identification, NICE...